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Abstract 
Tumor proliferation is an important biomarker indicative of the prognosis of breast cancer 
patients. Assessment of tumor proliferation in a clinical setting is a highly subjective and 
labor-intensive task. Previous efforts to automate tumor proliferation assessment by image 
analysis only focused on mitosis detection in predefined tumor regions. However, in a real-
world scenario, automatic mitosis detection should be performed in whole-slide images 
(WSIs) and an automatic method should be able to produce a tumor proliferation score given 
a WSI as input. To address this, we organized the TUmor Proliferation Assessment Challenge 
2016 (TUPAC16) on prediction of tumor proliferation scores from WSIs.  
The challenge dataset consisted of 500 training and 321 testing breast cancer histopathology 
WSIs. In order to ensure fair and independent evaluation, only the ground truth for the 
training dataset was provided to the challenge participants. The first task of the challenge was 
to predict mitotic scores, i.e., to reproduce the manual method of assessing tumor 
proliferation by a pathologist. The second task was to predict the gene expression based 
PAM50 proliferation scores from the WSI.  
The best performing automatic method for the first task achieved a quadratic-weighted 
Cohen’s kappa score of κ = 0.567, 95% CI [0.464, 0.671] between the predicted scores and 
the ground truth. For the second task, the predictions of the top method had a Spearman’s 
correlation coefficient of r = 0.617, 95% CI [0.581 0.651] with the ground truth. 
This was the first comparison study that investigated tumor proliferation assessment from 
WSIs. The achieved results are promising given the difficulty of the tasks and weakly-labeled 
nature of the ground truth. However, further research is needed to improve the practical 
utility of image analysis methods for this task. 
Keywords: breast cancer, cancer prognostication, tumor proliferation, deep learning  
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1. Introduction 
Tumor proliferation is an important biomarker indicative of the prognosis of breast cancer 
patients. Patients with high tumor proliferation have worse outcomes compared to patients 
with low tumor proliferation (van Diest et al., 2004). The assessment of tumor proliferation 
influences the clinical management of the patient – patients with aggressive tumors are 
treated with more aggressive therapies and patients with indolent tumor are given more 
conservative treatments that are preferred because of fewer side-effects (Fitzgibbons et al., 
2000).  
Tumor proliferation in a clinical setting is traditionally assessed by pathologists. The most 
common method is to count mitotic figures (dividing cell nuclei) on hematoxylin & eosin 
(H&E) histological slides under a microscope. The pathologists will assign a mitotic score of 
1, 2 or 3, where a score of 3 represents high tumor proliferation. Two other more objective 
methods that assess tumor proliferation in the breast include immunohistochemical staining 
for Ki67 protein (Cheang et al., 2009) and the molecular gene expression based PAM50 
proliferation score (Heng et al., 2017; Nielsen et al., 2010; The Cancer Genome Atlas 
Network, 2012). The lack of standardized procedures, debates about clinical utility, issues 
with Ki67 assay interpretation, and the complex molecular workflow to obtain gene 
expression has impeded the translation of Ki67 and PAM50 proliferation score for clinical 
use (Penault-Llorca and Radosevic-Robin, 2017). Ki67 and PAM50 proliferation score are 
significantly associated with mitotic counts (Heng et al., 2017; Lee et al., 2014), but their 
agreement is not perfect. There are limited studies investigating the relationship between 
molecular and morphological data, specifically, none has explored the potential of predicting 
PAM50 proliferation scores from H&E WSIs.  
Although mitosis counting is routinely performed in most pathology practices, this highly 
subjective and labor-intensive task suffers from reproducibility problems (Veta et al., 2016). 
One solution is to develop automated computational pathology systems to efficiently, 
accurately and reliably detect and count mitotic figures on histopathological images. Mitosis 
detection in WSIs is an active field of research  (Albarqouni et al., 2016; Chen et al., 2016, 
2016; Li et al., 2018; Tellez et al., 2018, 2018b). This interest was in large part supported by 
the availability of public datasets in the form of medical image analysis challenges. The first 
challenge on the topic of on mitosis detection was MITOS 2012 hosted at the International 
 4 
Conference of Pattern Recognition (ICPR) 2012 (Roux et al., 2013). In 2013, we organized 
AMIDA13 in conjunction with the International Conference on Medical Image Computing 
and Computer Assisted Intervention (MICCAI) conference (Veta et al., 2015). Mitosis 
detection was also one of the tasks of the MITOS-ATYPIA-14 challenge, organized as part of 
ICPR 2014, with the other task being scoring of nuclear atypia (Roux, 2014).  
A large limitation of all previous challenges was that they focused solely on mitosis detection 
in predetermined tumor regions of interest (ROIs). However, in a real-world scenario, 
automatic mitosis detection should be performed in WSIs and an automatic method should 
ideally be able to produce a breast tumor proliferation score given a WSI as input. To address 
this, we organized the TUmor Proliferation Assessment Challenge 2016 (TUPAC16). The 
main goal of the challenge was to evaluate (semi-)automatic methods to assess tumor 
proliferation from WSIs. In this paper, we present an overview of the submitted methods and 
results of the TUPAC16 challenge.  
1.1 Challenge format and tasks 
The challenge was organized in the context of MICCAI 2016 conference in Athens, Greece. 
The participants were able to register via the TUPAC16 website1 six months prior to the 
MICCAI 2016 conference, allowing ample time to develop their algorithms and submit 
results. Upon registration, the participants were provided with a training and testing dataset to 
develop an automatic tumor proliferation scoring method. Two auxiliary datasets that could 
aid the method development were also provided (see Materials and Methods section). In 
order to ensure fair and independent evaluation, only the ground truth for the training dataset 
was provided. The ground truth for the testing dataset was retained by the challenge 
organizers. 
The challenge had two main tasks to predict tumor proliferation. The first task was to predict 
mitotic scores. In essence, this task aims to reproduce the most common method of assessing 
tumor proliferation by a pathologist. The second task was to predict the gene expression 
based PAM50 proliferation scores. While it has been previously shown that PAM50 
proliferation scores correlate with manual mitotic scores (Heng et al., 2017), the goal of this 
                                               
1  http://tupac.tue-image.nl 
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task was to determine whether molecular scores can be predicted from tissue 
morphology/WSIs.  
A third task on mitosis detection was later added to the challenge upon request from the 
participants. This task was similar and related to the AMIDA13 challenge (Veta et al., 2015). 
However, due to the auxiliary nature of this task, we will not present an extensive overview 
in this paper and focus solely on the tumor proliferation assessment from WSIs. In brief, the 
top scoring method for the third task had an F1 score of 0.652 or mitosis detection. This is a 
slight improvement over the top scoring method of AMIDA13 challenge which had an F1 
score of 0.612. The results table for this task is available on the Results page published on the 
challenge website.   
All participating individuals or teams submitted their results for evaluation on the challenge 
website. In order to prevent overfitting on the test set, the number of submissions was limited 
to three per task. All submitted results before the deadline of October 3rd 2016 were presented 
at the challenge workshop and are included in this paper. Prior to the submission deadline, 
159 teams registered on the challenge website. Twelve teams submitted results for the first 
task2 and six teams submitted results for the second task.  
2. Materials and Methods 
2.1 Main dataset from The Cancer Genome Atlas 
The Cancer Genome Atlas (TCGA) Network was established to understand the molecular 
basis of 33 types of cancer. Specifically, the TCGA breast cancer team utilized genomic, 
transcriptomic and proteomic profiling technologies to characterize over 1200 invasive breast 
cancer cases (The Cancer Genome Atlas Network, 2012). Heng et al. (2017) subsequently 
curated a highly detailed histopathological annotation database for a subset of 850 TCGA 
breast cancer cases and integrated underlying molecular mechanisms with breast cancer 
morphological features.  
                                               
2  This overview paper includes he methods of 11 teams. The team with the lowest ranking method for 
the first task asked to be excluded from the overview paper (the results of this team are visible on the challenge 
website).  
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Each case in Heng et al. (2017) was represented by one WSI scanned at 40× magnification 
with an Aperio ScanScore scanner (Gutman et al., 2013). Cases were randomly assigned to a 
team of 15 international breast pathology experts to assess 12 breast cancer morphological 
features. Most features adhered to criteria established in clinical practice (Lester et al., 2009), 
criteria for certain features had to be modified to assess WSIs. In particular, the pathologists 
developed mitotic count thresholds specific to the TCGA study (Heng et al., 2017) where a 
score of 1 represents 0 to 5 mitotic counts per 10 HPFS at 40× magnification; a score of 2 
represents 6 to 10 mitotic counts per 10 HPFS; and a score of 3 for >10 mitotic counts per 10 
HPFS. To perform mitotic counting, the pathologists maximized their window screen size, 
pulled the zoom bar to the maximum and scanned each WSI to find an area with highest 
mitotic activity. Each on-screen area at maximum magnification was defined as a high 
powered field (HPF). The pathologists counted the number of mitoses per field in 10 
consecutive fields, excluded fields with scant numbers of tumor cells or necrosis, and the sum 
over the 10 fields was used to determine the score. Mitotic scores were available for 821 
cases, of which 311 were scored by at least two pathologists with an inter-rater reliability 
Krippendorff’s alpha of 0.488 and 78% agreement (Heng et al., 2017). In the 311 cases 
scored by more than one pathologist, a consensus was formed by taking the most common 
mitotic score (in case of a tie, the highest mitotic score was taken as the consensus). Gene 
expression based PAM50 proliferation score was available for all cases. The PAM50 
proliferation score is the average expression of 11 proliferation-associated genes part of the 
PAM50 gene signature: BIRC5, CCNB1, CDC20, CEP55, MKI67, NDC80, NUF2, PTTG1, 
RRM2, TYMS and UBE2C (Heng et al., 2017; Nielsen et al., 2010).  
Therefore, the main challenge dataset consisted of 821 TCGA WSIs with two types of tumor 
proliferation data: mitotic score (manual mitosis counting by the pathologists) and PAM50 
proliferation score (derived from gene expression). These 821 cases were randomly split into 
a training (n = 500) and testing (n = 321) set. In total, there are 383 cases with a mitotic score 
of 1, 194 cases with score 2 and 244 cases with score 3. The mean PAM50 proliferation score 
is -0.176 with a standard deviation of 0.428.  
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Table 1 – Distribution of the mitotic score (task 1) and PAM50 score (task 2) in the training 
and testing datasets. 
 Score 1 Score 2 Score 3 PAM50 score 
(mean ± STD) 
Training 236 (47%) 117 (23%) 147 (30%) -0.166 ± 0.446 
Testing 147 (46%) 77 (24%) 97 (30%) -0.192 ± 0.400 
 
2.2 Auxiliary datasets 
In addition to the main challenge dataset, two auxiliary datasets (ROI and mitosis detection) 
were also provided to the participants. These two datasets were to facilitate the design of a 
WSI tumor proliferation scoring system, e.g., by following a two-step approach to emulate 
how a pathologist would assess a slide for tumor proliferation: identify ROIs followed by 
mitotic counting.  
ROI dataset: The ROI auxiliary dataset contained 148 cases which were randomly selected 
from the training dataset (this auxiliary dataset did not contain WSIs from the test set). A 
blinded pathology resident annotated three ROIs to indicate where a pathologist might 
perform mitosis counting, adhering to standard clinical guidelines (Lester et al., 2009). 
Mitosis counting is performed in tumor regions that have high cellularity and are preferably 
located at the periphery. Note that these ROIs identified by the pathology resident may not 
necessarily overlap with the HPFS used by the team of pathologists who graded the mitotic 
scores in Heng et al. (2017). Examples of ROI annotations by the pathology resident in the 
auxiliary ROI dataset are given in Figure 1.  
Mitosis detection dataset: The mitosis detection dataset consisted of WSIs from 73 breast 
cancer cases from three pathology centers with annotated mitotic figures by consensus of 
three observers. Of the 73 cases, 23 were previously released as part of the AMIDA13 
challenge (Veta et al., 2015). These cases were collected from the Department of Pathology 
at the University Medical Center in Utrecht, The Netherlands. Each case was represented 
with varying number of HPFS extracted from WSIs acquired with the Aperio ScanScope XT 
scanner at 40× magnification with a spatial resolution of 0.25 µm/pixel. 
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Figure 1 – Examples of two low magnification whole slide images in the auxiliary region of 
interest (ROI) dataset annotated with three ROIs (green rectangle boxes) each by a pathology 
resident. These ROIs represent areas where a pathologist might perform mitosis counting.  
The remaining 50 cases previously used to assess the inter-observer agreement for mitosis 
counting were from two other pathology centers in The Netherlands (Symbiant Pathology 
Expert Center, Alkmaar and Symbiant Pathology Expert Center, Zaandam) (Veta et al., 
2016). Each case was represented by one WSI region with an area of 2 mm2. These WSIs 
were obtained using the Leica SCN400 scanner (40× magnification and spatial resolution of 
0.25 µm/pixel). The annotated mitotic figures are the consensus of at least two pathologists, 
similar to the AMIDA13 challenge. In total, the mitosis detection auxiliary dataset contained 
1552 annotated mitotic figures (Figure 2).  
  
Figure 2 – Examples from the mitosis detection auxiliary dataset with annotated mitotic 
figures (green circles). These annotated mitotic figures are the consensus of at least two 
pathologists. 
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2.3 Summary of the submitted methods 
All submitted methods broadly fell into two groups depending on the main strategy to predict 
proliferation scores from WSIs. The first group of methods followed a pathologist’s two-step 
approach: identify ROIs followed by performing mitosis counting within the selected regions. 
The prediction for the tumor proliferation scores was based on the response of the mitosis 
detector. The second group of methods followed a more direct strategy. The first step was 
also ROI detection, however, mitosis detection was not performed and the prediction of 
tumor proliferation scores was based on the overall appearance of the ROIs. All teams 
followed similar strategy for the prediction of both proliferation scores.  
With the exception of one team, all participants/teams used deep convolutional neural 
networks as part of the processing pipeline. Table 2 presents an overview of the main 
characteristics of all submitted methods in the challenge. The remainder of this subsection 
summarizes the main characteristics of the proposed methods. A more detailed description of 
the individual methods can be found in the Supplementary Materials. 
Preprocessing and ROI detection: One of the major hurdles in histopathology image 
analysis is the variability of tissue appearance. The staining color and intensity can be 
significantly different between WSIs due to variation in tissue preparation, staining and 
digitization processes. To address this, the majority of submitted method performed staining 
normalization as a preprocessing step. The most commonly used method was the one 
proposed by Macenko et al. (2009). This unsupervised method heuristically estimates the 
absorbance coefficients for the H&E stains for every image and the staining concentrations 
for every pixel. Normalization was performed by recomposing the RGB images from the 
staining concentration maps using common absorbance coefficients. 
Since large portions of the WSIs are background, many of the proposed methods resort to 
tissue segmentation by thresholding such as Otsu’s method (Otsu, 1979). The HEIDELBERG 
team also detected artifacts such as marker annotations or tissue folds based on heuristic 
mapping that highlights them. 
The ROI auxiliary dataset contained non-exhaustive annotations of tumor areas where mitosis 
detection can be performed. Two teams used this data to train a one-class classifier. The IBM 
team trained a convolutional autoencoder with the provided ROIs and used the reconstruction 
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error as metric to identify ROIs in test images. BELARUS identified ROIs using the L1 
similarity of co-occurrence features to the ground truth ROIs (Kovalev et al., 2001).  
SECTRA and WARWICK made in-house annotations of non-ROI regions and used this data 
to train a supervised ROI detection method (note that the annotated ROIs were used only for 
training). The method proposed by HARKER also trained a supervised model for ROI 
detection, however instead of manual annotation for the negative class, HARKER made the 
assumption that all regions that were not annotated were negative. LUNIT detected ROIs 
based on cell/nuclei density estimated with CellProfiler (Kamentsky et al., 2011). The 
MICROSOFT team used manually selected ROIs annotated by an external pathologist3. 
Therefore, their method was classified as semi-automatic.  
Mitosis detection: All teams that performed mitosis detection as part of the proliferation 
scoring pipeline used deep convolutional neural networks. Most teams trained a two-class 
classification model: patches centered at a mitotic figure and background patches. On the 
testing dataset, the model evaluated every pixel location and produced a mitosis probability 
map that could be further processed to identify mitotic figures and/or produce a mitotic score 
for a ROI. The neural network architectures applied to this problem vary from relative 
“shallow” networks with only a few convolutional layers (CONTEXTVISION and SECTRA) 
to deep residual neural networks (LUNIT and IBM) (He et al., 2015).  
The mitosis detection model by HEIDELBERG did not follow the patch-based approach. 
They trained a model that incorporated a Hough voting layer – each pixel location predicted 
the radius and angle to the nearest mitotic figure.  
Since mitoses are generally rare events, even in high grade cancers, the mitosis/background 
classification problem is very unbalanced. In order to remedy this, the majority of submitted 
methods resorted to two strategies. The first strategy was data augmentation by geometric 
transformations of the training samples. The mitosis detection problem is invariant to 
rotations, flipping and small translation and scaling. This can be exploited to create new 
plausible training samples to enrich the training data.  
                                               
3  This additional data and the manually annotated ROIs in the testing set used by the MICROSOFT 
team are available on the TUPAC16 website.  
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The other strategy was hard negative mining, which was first proposed for mitosis detection 
by Cireşan et al. (2013). With this boosting-like technique, an initial mitosis detection 
method is trained with random sampling for the background class and then used to detect 
“difficult” negative instances that are used to train a second method. In practice, models 
trained with random sampling for the background class result in a large number of false 
positives since all hyperchromatic objects (e.g. lymphocytes, apoptotic nuclei, necrotic nuclei 
etc) are detected as mitoses. The output of the initial mitosis detection method can be used to 
sample such difficult background samples and train a second mitosis detection method. This 
commonly leads to significant improvements of the mitosis detection accuracy.   
Prediction of tumor proliferation score for Task 1: CONTEXTVISION, SECTRA, 
HEIDELBERG and FLORIDA predicted proliferation scores for the first task with heuristic 
methods based on combining the results from the detection of ROIs and mitoses. For 
instance, CONTEXTVISION computed a proliferation score for every detected ROI by 
counting the number of pixels in the mitosis probability map above a certain threshold value 
that was optimized by cross-validation. A slide-level score was produced by taking the 
maximum over all ROIs. The final prediction was made by quantizing the slide-level score 
into one of the three grades based on the grade distribution in the training set. Similarly, 
SECTRA computed a ROI score that combined the number of detected mitotic figures and 
the per-pixel average of the mitosis detection model. A slide-level score was computed by 
averaging the scores for all detected ROIs and then stratified into three categories using two 
threshold values optimized on the training set. HEIDELBERG computed a slide-level 
proliferation score as the 95th-percentile of the mitotic counts for the detected ROIs. 
LUNIT, IBM, HARKER and WARWICK predicted the proliferation score with a classifier 
that used a combination of features based on the output of the mitosis detection method and 
global ROI features. LUNIT trained a support vector machine (SVM) classification model 
using a set of features that summarized the statistics of the number of detected mitoses and 
nuclei in 30 ROIs. IBM trained a random forest classifier using global color and texture 
features (average intensity of the RGB channels, contrast, energy and homogeneity) and 
number of detected mitoses at four different detection levels in six ROIs.  
Three of the proposed methods (BELARUS, RADBOUD and MICROSOFT) followed a 
direct strategy for predicting proliferation scores that did not rely on mitosis detection. 
BELARUS was the only team that did not employ deep neural networks in any part of the 
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processing pipeline and predicted the tumor proliferation score with a linear classifier trained 
with a set of co-occurrence features (Kovalev et al., 2001). The method submitted by 
RADBOUD was unique among the submissions since it did not rely on ROI detection. 
Instead, large image patches from a low magnification level of the WSI (4096´4096 pixels, 
5´ magnification) were cropped with data augmentation and used as input into a deep neural 
network model to predict the proliferation score. MICROSOFT computed features in the 
manually annotated ROIs with a pre-trained ResNet model (He et al., 2015) and then trained 
a RankSVM (Joachims, 2002) with a linear kernel to make the predictions.  
Prediction of proliferation score for Task 2: All six teams that participated in the second 
task used a similar or identical approach as for the first task, e.g. by using a regression instead 
of a classification model. 
2.4 Evaluation 
The first task was evaluated using the quadratic weighted Cohen’s kappa statistic for inter-
rater agreement between the ground truth and the predictions. This variant of Cohen’s kappa 
puts higher weight on larger errors in the predicted grade (e.g. “1” instead of “3” or vice 
versa) that are of higher clinical consequence. The second task was evaluated with the 
Spearman’s correlation coefficient between the prediction and the ground truth PAM50 
proliferation scores.  
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Table 2 – Summary of the submitted methods. 
Team name Use of 
additional 
training data 
Preprocessing ROI detection Mitosis detection Predictions for Task 1 Predictions for Task 2 
LUNIT 
 
Lunit Inc., Korea  
No Tissue segmentation 
with Otsu 
thresholding (Otsu, 
1979); staining 
normalization 
(Macenko et al., 
2009) 
Based on cell density 
estimated with 
CellProfiler 
(Kamentsky et al., 
2011) 
ResNet architecture 
(He et al., 2015); 
hard negative 
mining  
SVM classifier with 21 types of 
features related to cell and 
mitotic figures density 
 
Rank for Task 1: 1  
SVM for regression, same 
features as for Task 1 
 
Rank for Task 2: 2 
CONTEXTVISION 
 
Contextvision, Sweden 
(SLDESUTO-BOX)
  
No None Based on heuristic 
mapping of the color 
channels that highlights 
dark tumor areas 
Architecture similar 
to Cireşan et al. 
(2013); hard 
negative mining 
Heuristic based on the response 
on mitosis detection in the ROIs 
 
Rank for Task 1: 3 
Same as for Task 1 
 
Rank for Task 2: 4 
SECTRA 
 
Sectra, Sweden  
Yes; non-ROI 
annotations 
None Based on classification 
with a four-layer CNN 
Six-layer CNN; 
hard negative 
mining 
Heuristic based on the response 
on mitosis detection in the ROIs 
 
Rank for Task 1: 4 
d.n.p. 
HEIDELBERG 
 
University of Heidelberg, 
Germany  
No Artifact detection 
based on heuristic 
mapping of the 
color channels that 
highlights ink and 
tissue folding 
Based on heuristic 
mapping of the color 
channels that highlights 
dark tumor areas  
 
 
Novel architecture 
that combine 
residual networks 
with Hough voting 
(Wollmann and 
Rohr, 2017); hard 
negative mining 
Thresholds for the number of 
detected mitotic figures 
optimized using the quadratic 
weighted Cohen’s kappa score 
 
Rank for Task 1: 5 
d.n.p. 
IBM 
 
IBM Research Zurich 
and Brazil 
Yes; ICPR 
2012 and 2014 
datasets 
Staining 
normalization 
(Macenko et al., 
2009) 
One-class classification 
based on the 
reconstruction error of 
convolutional 
autoencoders 
Wide residual 
network 22-2 
architecture 
(Zagoruyko and 
Komodakis, 2016); 
hard negative 
mining 
Random forest classifier using 
color, texture and number of 
mitoses features in the detected 
ROIs 
 
Rank for Task 1: 6 
d.n.p. 
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HARKER 
 
The Harker School, 
United States  
No Tissue segmentation 
with Otsu 
thresholding (Otsu, 
1979); staining 
normalization 
(Ehteshami 
Bejnordi et al., 
2015) 
Based on classification 
with four neural 
network architectures: 
GoogLeNet (Szegedy et 
al., 2014), ResNet-34 
(He et al., 2015), VGG-
13 (Simonyan and 
Zisserman, 2014) and 
custom architecture 
Custom CNN 
architecture; hard 
negative mining; 
end-to-end models 
for predicting the 
mitotic score from 
the ROIs 
Combination random forest, 
SVM and gradient boosting 
classifiers using a combination 
of features from the ROI 
detection, mitosis detection and 
end-to-end models 
 
Rank for Task 1: 7 
Regression with the same 
features as for Task 1 
 
Rank for Task 2: 6 
BELARUS 
 
Belarus National 
Academy of Sciences
  
No Staining 
decomposition; the 
hematoxylin 
channel was used in 
all subsequent 
processing 
One-class classification 
based on L1 similarity 
with co-occurrence 
features (Kovalev et al., 
2001) 
n/a 
 
Direct prediction using a linear 
classifier with co-occurrence 
features (average of prediction 
for 20 ROIs) 
 
Rank for Task 1: 8 
Regression with the same 
features as for Task 1 
 
Rank for Task 2: 5 
RADBOUD 
 
Radboud UMC 
Nijmegen, The 
Netherlands  
No Tissue detection 
with thresholding; 
Staining 
normalization 
(Ehteshami 
Bejnordi et al., 
2015) 
n/a n/a End-to-end prediction using a 
custom CNN architecture 
(average of 500 predictions for 
randomly cropped regions) 
 
Rank for Task 1: 9 
Same as for Task 1 
 
Rank for Task 2: 3 
FLORIDA 
 
University of South 
Florida, United States 
No Staining 
normalization 
(Macenko et al., 
2009) 
Based on heuristic 
mapping of the color 
channels that highlights 
dark tumor areas 
AlexNet 
architecture 
(Krizhevsky et al., 
2012) 
Heuristic thresholds for the 
number of detected mitotic 
figures in the ROIs 
 
Rank for Task 1: 10 
d.n.p. 
WARWICK 
 
University of Warwick, 
United Kingdom  
Yes; non-ROI 
annotations 
None Based on tumor 
segmentation with U-
Net-like architecture 
(Ronneberger et al., 
2015)  
Two-stage CNN 
detector 
Random forest classifier using 
number of mitoses features in 
the detected ROIs 
 
Rank for Task 1: 11 
d.n.p. 
MICROSOFT  
 
Microsoft Research Asia, 
China  
No Staining 
normalization 
(Macenko et al., 
2009) 
Manual ROI selection n/a RankSVM with linear kernel 
(Joachims, 2002); feature 
extraction was done with 
ResNet (He et al., 2015) and P-
norm pooling(Xu et al., 2015) 
 
Rank for Task 1: 2 (note: semi-
automatic method) 
 
Same as for Task 1 
 
Rank for Task 2: 1 (note: 
semi-automatic method) 
 
d.n.p. – did not participate for this task 
n/a - not applicable for this method  
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3. Results 
The results for the first task in the challenge (prediction of tumor proliferation score based on 
mitosis counting) are summarized in Table 3. The top performing method was by LUNIT 
with a quadratic weighted kappa statistic of κ = 0.567, 95% CI [0.464, 0.671]. The semi-
automatic method by MICROSOFT and the method submitted by CONTEXTVISION had 
similar performances of κ = 0.543, 95% CI [0.422, 0.664] and κ = 0.534, 95% CI [0.422, 
0.646], respectively. Table 4 presents the confusion matrices of the predictions using the 
methods by LUNIT, MICROSOFT and CONTEXTVISION (the confusion matrices for all 
methods can be found in the Supplementary Materials), along with an ensembling by average 
voting of the top 3 automatic methods (see section 3.1). As evident by the per-class 
accuracies, mitotic score 2 was the most commonly misclassified (per-class accuracy of 17%, 
50% and 31% for LUNIT, MICROSOFT and CONTEXTVISION).  
Table 3 – Results for Task 1.  
 Team κ † 95% CI 
1 LUNIT 0.567 [0.464, 0.671] 
2 MICROSOFT* 0.543 [0.422, 0.664] 
3 CONTEXTVISION 0.534 [0.422, 0.646] 
4 SECTRA 0.462 [0.340, 0.584] 
5 HEIDELBER 0.417 [0.293, 0.540] 
6 IBM 0.385 [0.266, 0.504] 
7 HARKER 0.367 [0.242, 0.492] 
8 BELARUS 0.321 [0.190, 0.452] 
9 RADBOUD 0.290 [0.171, 0.409] 
10 FLORIDA 0.177 [0.052, 0.302] 
11 WARWICK 0.159 [0.023, 0.294] 
* Semi-automatic method 
† Quadratic weighted Cohen’s kappa statistic 
 
Table 5 summarizes the results of PAM50 proliferation score prediction. The best 
performance was achieved by the semi-automatic method by MICROSOFT (r = 0.710, 95% 
CI [0.681 0.737]). The best scoring automatic method was LUNIT with a Spearman 
correlation coefficient between the ground truth and predicted scores of r = 0.617, 95% CI 
[0.581 0.651], followed by RADBOUD with r = 0.516, 95% CI [0.474 0.556]. The 
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scatterplots between the ground truth and predicted PAM50 proliferation scores for the 
MICROSOFT, LUNIT and RADBOUD methods are in Figure 3. Scatterplots for all methods 
can be found in the Supplementary Materials along with evaluation of the agreement between 
the prediction and the ground truth in terms of the intraclass correlation coefficient.  
 
Table 4 –Confusion matrices for the LUNIT (A), MICROSOFT (B) and CONTEXTVISION 
(C) methods and the ensembling by average voting of the top three automatic methods 
(LUNIT, CONTEXTVISION and SECTRA; D). 
 LUNIT  MICROSOFT* 
A  
 
Predicted   
1 2 3 Acc. 
Ground 
truth 
1 117 11 19 80% 
2 40 13 24 17% 
3 16 8 73 75% 
 
B  
 
Predicted   
1 2 3 Acc. 
Ground 
truth 
1 99 44 4 67% 
2 26 39 12 50% 
3 11 46 40 41% 
 
 κ = 0.567 
95% CI [0.464, 0.671] 
 
 κ = 0.543 
95% CI [0.422, 0.664] 
 CONTEXTVISION  Ensembling by average voting of 
LUNIT, CONTEXTVISION and 
SECTRA 
C  
 
Predicted   
1 2 3 Acc. 
Ground 
truth 
1 103 29 15  70% 
2 35 24 18 31% 
3 14 22 61 62% 
 
D  
 
Predicted   
1 2 3 Acc. 
Ground 
truth 
1 107 36 4 73% 
2 36 29 12 38% 
3 7 40 50 52% 
 
 κ = 0.534 
95% CI [0.422, 0.646] 
 κ = 0.613 
95% CI [0.504, 0.722] 
 
* Semi-automatic method 
Acc. – per-class accuracy for the three mitotic scores 
 
Table 5 – Results for Task 2.  
 Team r† 95% CI 
1 MICROSOFT* 0.710 [0.681 0.737] 
2 LUNIT 0.617 [0.581 0.651] 
3 RADBOUD 0.516 [0.474 0.556] 
4 CONTEXTVISION 0.503 [0.460 0.544] 
5 BELARUS 0.494 [0.451 0.535] 
6 HARKER 0.474 [0.429 0.516] 
* Semi-automatic method 
† Spearman correlation coefficient 
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3.1 Method ensembling 
Exploratory experiments with model ensembling were performed by averaging the results of 
the top three automatic methods (the semi-automatic methods by MICROSOFT were 
excluded from this analysis). For the first task, the predicted scores from the top three 
automatic methods (LUNIT, CONTEXTVISION and SECTRA) were averaged and rounded 
to the nearest integer. This resulted in a score of κ = 0.613, 95% CI [0.504, 0.722], which is 
an improvement by 0.046 over the best individual method by LUNIT (κ = 0.567, 95% CI 
[0.464, 0.671]). For the second task, the predictions by the top three automatic methods 
(LUNIT, RADBOUD and CONTEXTVISION) were first scaled to zero-mean and unit-
variance and then averaged. This was necessary in order to account for the different scales of 
the predictions. The combined prediction resulted in a Spearman correlation coefficient of r = 
0.682, 95% CI [0.651 0.711], which is an improvement by 0.065 over the best individual 
method by LUNIT (r = 0.617, 95% CI [0.581 0.651]; Figure 3D).  
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A 
 
B 
 
  
r = 0.710, 95% CI [0.681 0.737] 
 
  
r = 0.617, 95% CI [0.581 0.651] 
 
C 
 
 
D 
 
  
r = 0.516, 95% CI [0.474 0.556] 
  
r = 0.682, 95% CI [0.651 0.711] 
 
Figure 3 – Results for Task 2. Scatter plots for the MICROSOFT (A), LUNIT (B) and 
RADBOUD (C) methods and the average voting of the top three automatic methods (LUNIT, 
RADBOUD and CONTEXTVISION; D). 
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4. Discussion 
Tumor proliferation is an important pathological assessment that aids the clinical 
management of cancer patients. The current method to assess tumor proliferation is manual 
mitosis counting by pathologists. This process is highly subjective and time consuming. An 
automatic computational pathology proliferation assessment method will save time and lead 
to the standardization of mitotic scores across institutions. The TUPAC16 challenge was 
created to advance the state of the art in automatic assessment of tumor proliferation from 
WSIs and improve upon previous challenges that focused solely on mitosis detection. 
The first task of the challenge was to predict a mitosis-based tumor proliferation score. 
The best performing method (LUNIT) achieved a quadratic-weighted Cohen’s kappa score of 
κ = 0.567, which signifies a moderate agreement with the manual ground truth. This κ 
score was lower compared to previous work. In Veta et al. (2016), the inter-observer 
agreement between pathologists was estimated between κ = 0.792 and κ = 0.893. The 
higher κ agreement in Veta et al. was most likely due to the three pathologists 
performing mitosis counting in a predefined area, which considerably increases the chances 
for a concordant score as it eliminates the tumor heterogeneity factor, compared to the first 
task of the challenge where the teams may have predicted mitotic scores in ROIs different 
from the pathologists in Heng et al. (2017). All three best performing methods for the first 
task also made a substantial number of errors whereby the predicted and ground truth 
scores differed by two (Table 4). Such discordance may lead to more severe clinical 
implications, however similar errors can also potentially occur with manual scoring (Al-
Janabi et al., 2013; Robbins et al., 1995), although to a lesser extent. 
The manual scoring of tumor proliferation by mitosis counting involves a multi-scale analysis 
of the tissue. Thus, training an automatic method that predicts mitotic scores using only 
global, slide-level annotations is a challenging task. It should also be noted that the mitosis 
detection auxiliary dataset, which was used by the majority of teams to train a mitosis 
detector that formed the basis of the proliferation scoring models, was obtained from three 
Dutch medical centers and are different from the TCGA USA medical institutions that 
provided the main dataset. This constitutes a domain shift when the mitosis detector trained 
with the auxiliary dataset is applied to main dataset, which further increases the difficulty of 
this task. 
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The top performing automatic methods in the first task followed a two-stage approach that 
emulates the scoring by pathologists. However, the individual building blocks vary between 
the methods. While the method by LUNIT performs mitosis detection with a very deep 
ResNet architecture (He et al., 2015), the methods by SECTRA and CONTEXTVISION that 
achieved a comparable performance used a comparatively “shallower” neural network 
architecture. LUNIT use a staining normalization approach (Macenko et al., 2009) to 
standardize the appearance of the tissue prior to further processing and the mitosis detector 
used by SECTRA works on grayscale images at a two times reduced resolution (0.5 
µm/pixel). The top three automatic methods for the first task used different ROI detection 
methods (heuristic color channel mapping, cell-density based detection and CNN classifier) 
and different methods for computing a slide-level proliferation score (SVM classifier, 
heuristic based on the response of the mitosis detector). The varied method design is likely 
responsible for the performance boost when ensembling the predictions of the top three 
methods (κ = 0.613 for the average voting).   
The second task of the challenge has the built-in hypothesis that the molecular PAM50 
proliferation score can be predicted from WSIs. The MICROSOFT, NIJMEGEN and 
BELARUS methods predicted the tumor proliferation scores for both tasks using region-level 
features, without resorting to mitosis detection as an intermediate step. Although their 
methods worked particularly well for the second task and achieved good correlation, the best 
performing automatic method by LUNIT still relied on mitosis counting. The results from the 
second task accepted our hypothesis that the molecular PAM50 proliferation score could be 
predicted from WSIs. Predicting molecular scores from WSIs could potentially be a new 
clinical and research tool to assess tumor proliferation.  
All proposed methods except one can be characterized as automatic as they do not require 
manual input at test time. The MICROSOFT method is semi-automatic as it requires the ROI 
regions to be manually selected at test-time. While such an approach has more limited utility 
compared to automatic methods, it can still be valuable in clinical practice. For example, 
pathologists can request the method to be executed on the same ROIs where they assessed 
mitotic counts. 
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4.1 Recommendations for future work and conclusion 
TUPAC16 was the first challenge to predict tumor proliferation scores from WSIs. The main 
goal was to gain insights into automatic solutions for this problem and set the state of the art. 
As tumor proliferation is an important prognostic biomarker for breast cancer, we expect that 
this topic will continue to be of relevance in the future. In this subsection, we provide 
recommendations for subsequent research and challenges on this topic. 
Modular submission format: The majority of the submitted methods used a pipeline that 
consisted of four major processing steps: pre-processing, ROI detection, mitosis detection 
and slide-level prediction. Due to the heterogeneity of the top scoring methods, it is difficult 
to draw conclusions about design choices that positively impacted the performance of the 
methods. One of the major drawbacks of the TUPAC16 challenge setup was that it was not 
feasible to conduct quantitative evaluation on how each image analysis pipeline component 
impacted the performances of the methods. One solution for future challenges is to request 
submissions in a modular Docker format. With this setup, the different processing blocks will 
be submitted as separate Docker containers that are combined to produce the final 
submission. The use of Docker containers for submission can improve the reproducibility of 
the submissions and reduce the chance of cheating (Maier-Hein et al., 2018). The modular 
format can enable evaluating methods that are combinations of building blocks submitted by 
different teams and facilitate marginalization of the impact of individual design choices, e.g., 
by evaluating all methods on a predefined set of ROIs or with standardized/baseline mitosis 
detection. 
Evaluation on datasets from external domains: Systematic differences in the appearance 
of the WSIs obtained from different pathology laboratories is one of the major hurdles in 
histopathology image analysis. Future challenges and research on this topic should have an 
experimental setup to evaluate the performance of the methods under a domain shift. 
Minimally, the independent testing set should include a subset of cases from a domain that 
was not included in the training set (e.g. a different pathology laboratory or scanner 
manufacturer).  
Investigate the relationship between global/regional features and proliferation: A 
particularly interesting finding of this challenge was that both proliferation scores can be 
predicted with reasonable accuracy from ROI-level features, without resorting to mitosis 
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detection. Future research efforts should focus on investigating the relationship between 
global or regional image features and tumor proliferation, such as visualizing the learned 
features that are predictive of high tumor proliferation. This can be particularly of interest for 
the PAM50 proliferation score as it can establish a relationship between molecular and 
morphological tissue characteristics. 
Evaluation in terms of prognostication: The ultimate goal of tumor proliferation 
assessment is to guide clinical management and predict patient outcome. We recommend that 
future work on this topic also evaluate the proposed methods in terms of predicting the 
overall or disease-specific survival of breast cancer patients.  
The performance of the automatic and semi-automatic methods submitted to this challenge 
did not reach a level that is sufficient to be used as a “second opinion” score. The results from 
the challenge are promising given the difficulty of the tasks and weakly-labeled nature of the 
ground truth, and have provided valuable insight into this problem. However, further research 
is needed to improve the practical utility of image analysis methods. 
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Supplementary Material 
S1 Method description, available at: 
http://tupac.tue-image.nl/system/files/Supplementary%20material%201%20%28rev%29.pdf 
S2 Results for all submitted methods, available at: 
http://tupac.tue-image.nl/system/files/Supplementary%20material%202%20%28rev%29.pdf 
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